phs000280.v5.p1 Atherosclerosis Risk in Communities (ARIC) Cohort | Versions 1-5: passed embargo
| VDAS | 15678 | Longitudinal, Cohort | | |
phs000007.v30.p11 Framingham Cohort | Versions 1-30: passed embargo
| VDAS | 15154 | Longitudinal | | HuGeneFocused50K_Affy Mapping250K_Nsp Mapping250K_Sty Mapping50K_Hind240 Mapping50K_Xba240
|
phs000285.v3.p2 CARDIA Cohort | Versions 1-3: passed embargo
| VDAS | 3622 | Longitudinal | Links | |
phs000090.v4.p1 GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study | Versions 1-4: passed embargo
| VDAS | 12771 | Case-Control | | AFFY_6.0
|
phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) Cohort | Versions 1-13: passed embargo
| VDAS | 8296 | Longitudinal, Family | Links | |
phs000128.v3.p3 GAW16 Framingham and Simulated Data | Versions 1-3: passed embargo
| VDAS | 7096 | Longitudinal, Population | Links | Mapping250K_Nsp Mapping250K_Sty Mapping50K_Hind240 Mapping50K_Xba240
|
phs000308.v1.p1 The Glaucoma Genes and Environment (GLAUGEN) Study | Version 1: passed embargo
| VDAS | 2289 | Case-Control | Links | Human660W-Quad_v1_A
|
phs000200.v12.p3 Women's Health Initiative | Versions 1-11: passed embargo Version 12:
| VDAS | 143213 | Partial Factorial Randomized, Double-Blind, Placebo-Controlled, Cohort, Longitudinal | Links | |
phs000017.v3.p1 Whole Genome Association Study of Bipolar Disorder | Versions 1-3: passed embargo
| VDAS | 3261 | Case-Control | Links | AFFY_6.0
|
phs000086.v3.p1 DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes | Versions 1-3: passed embargo
| VDAS | 1497 | Clinical Trial, Longitudinal | Links | HumanHap550v3.0 ILLUMINA_Human_1M
|
phs000287.v6.p1 Cardiovascular Health Study (CHS) Cohort | Versions 1-6: passed embargo
| VDAS | 5609 | Longitudinal | | |
phs000594.v1.p1 A Phase 2 Study of Tipifarnib in Large Granular Lymphocyte (LGL) Leukemia | Version 1: passed embargo
| VDAS | 9 | Interventional, Clinical Trial | Links | |
phs000343.v3.p1 The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention Stroke Prevention (VISP) trial | Versions 1-3: passed embargo
| VDAS | 2164 | Multicenter, Randomized, Clinical Trial, Double-Blind, Controlled Trial | | HumanOmni1-Quad_v1-0_B
|
phs000363.v17.p11 NHLBI Framingham SABRe CVD | Versions 1-17: passed embargo
| VDAS | 7558 | Cohort | | GeneChip Human Exon 1.0 ST Array Custom Panel TaqMan 350 MicroRNA Custom Panels
|
phs000091.v2.p1 GENEVA Diabetes Study (NHS/HPFS) | Versions 1-2: passed embargo
| VDAS | 6033 | Nested Case-Control | Links | AFFY_6.0
|
phs000309.v3.p2 The CARDIA-GENEVA Study | Versions 1-3: passed embargo
| VDAS | 1926 | Longitudinal | Links | AFFY_6.0
|
phs000001.v3.p1 NEI Age-Related Eye Disease Study (AREDS) | Versions 1-3: passed embargo
| VDAS | 4757 | Case-Control | Links | ILMN_Human-1 Mapping50K_Hind240 Mapping50K_Xba240
|
phs000592.v1.p1 Screening Protocol and Longitudinal Study of Bone Marrow Failure Syndromes and Cytopenias | Version 1: passed embargo
| VDAS | 341 | Longitudinal, Prospective | Links | |
phs000577.v1.p1 UCDC Longitudinal Study | Version 1: passed embargo
| VDAS | 542 | Longitudinal | Links | |
phs000375.v1.p1 Genome-Wide Association of Platelet Phenotypes | Version 1:
| VDAS | | Family, Cohort | Links | ILLUMINA_Human_1M
|